CRVS

CORVUS PHARMACEUTICALS INC

CRVS·221015100·US·Common Stock·Healthcare - Biotechnology-Activist

CRVS (CORVUS PHARMACEUTICALS INC) is held by 83 institutional investors as of Q1 2026. Largest holders: BlackRock, Inc. ($90.1M), STATE STREET CORP ($52.2M), VANGUARD CAPITAL MANAGEMENT LLC ($47.3M). Net institutional sentiment: Bullish.

83
Holders
Avg rating(18 Elite)
$520.6M
Total Value
67% (96)
Fund Consensus
64 buying - 31 selling
CRVSSmart Money Verdict
View all
Held by 83 funds
18 elite
Who's Trading
InsiderMMMILLER RICHARD A MDBuy $23KMay 18, 2026
InsiderMMMILLER RICHARD A MDBuy $60KMay 18, 2026
ActivistPoint72 Asset Management, L.P.Point72 Asset Management, L.P.0.0%May 15, 2026
ActivistSISirenia Capital Management LP7.5%May 15, 2026
ActivistBlackRock, Inc.BlackRock, Inc.6.4%Apr 27, 2026
ActivistThe Vanguard GroupThe Vanguard Group0.0%Mar 26, 2026
ActivistRARichard A. Miller7.8%Feb 13, 2026
ActivistASAdams Street Partners, LLC3.9%Feb 5, 2026
InsiderTAThompson Peter A.Sell $4.9MJun 27, 2025
InsiderOLORBIMED ADVISORS LLCSell $4.9MJun 27, 2025
13F: Insider & Congress:
Fund
Action
Shares
Value
Weight
Est. P&L
Conviction
Increased
6.2M(+21.8%)$90.1M0.0%+122.91%
36
Increased
3.6M(+27.9%)$52.2M0.0%+75.20%
37
New
3.2M$47.3M0.0%-10.61%
40
Increased
2.9M(+8453.9%)$42.7M0.0%-9.84%
47
Decreased
2.5M(-30.0%)$36.6M0.0%+133.96%
0
Increased
2.3M(+636.8%)$33.9M0.0%-1.93%
47
Increased
1.7M(+16.3%)$25.1M0.0%+170.85%
33
Increased
1.5M(+178.5%)$22.5M0.0%+14.89%
46
New
1.3M$19.5M0.2%-10.61%
47
New
1.1M$15.7M0.1%-10.61%
39
Increased
866,362(+25.8%)$12.7M0.0%+64.12%
34
New
750,000$11M0.0%-10.61%
38
New
669,895$9.8M0.0%-10.61%
38
Increased
548,285(+153.5%)$8M0.0%+15.47%
44
Increased
539,869(+276.0%)$7.9M0.0%+13.87%
44
Increased
506,104(+17.8%)$7.4M0.0%+152.33%
32
New
504,631$7.4M0.0%-10.61%
38
New
450,000$6.6M0.1%-10.61%
38
Increased
442,522(+112.6%)$6.5M0.0%+22.55%
44
Increased
289,114(+36.4%)$4.2M0.0%+73.06%
35

Showing 1-20 of 96

1 / 5

Other Healthcare stocks held by institutions

Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used